Compositions useful for the treatment of immune-related diseases

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11229670
APP PUB NO 20190269736A1
SERIAL NO

16461834

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a gingival fibroblast-derived product for use in the treatment or prevention of an immune-related disease in an individual.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • SCARCELL THERAPEUTICS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Coulomb, Bernard Igny, FR 17 66
Lafont, Antoine Paris, FR 23 454

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 25, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 25, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 25, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00